Skip to main content
Clinical Trials/ChiCTR2200056605
ChiCTR2200056605Active, not recruitingNot Applicable

脊麻与静脉全麻对宫腔镜子宫内膜切除术患者膨宫液吸收的影响

自筹1 site in 1 country126 target enrollmentStarted: February 3, 2022Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Active, not recruiting
Sponsor
Enrollment
126
Locations
1
Primary Endpoint
红细胞压积

Study Overview

Brief Summary

1.观察各组患者术中膨宫液吸收量及各组患者 HCT 情况 2.记录各组患者术中补液量和术中术后肺水肿、恶心呕吐并发症情况,以及住院时间。

Study Design

Study Type
观察性研究
Primary Purpose
连续入组

Eligibility Criteria

Ages
28 to 60 (—)
Sex
Female

Inclusion Criteria

  • 2、BMI 18.5~24kg/m2
  • 3、病人无严重肝、肾和心血管疾病
  • 4、认知功能和意识状态无异常
  • 6、无药物或酒精成瘾史

Exclusion Criteria

  • 2、脊柱畸形或腰椎穿刺部位感染
  • 3、Hb<100g/L
  • 5、伴有粘膜下子宫肌瘤
  • 7、宫颈或子宫内膜癌前病变。

Arms & Interventions

Case series

No

Outcomes

Primary Outcomes

红细胞压积

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
自筹

Study Sites (1)

Loading locations...

Similar Trials

脊麻与静脉全麻对宫腔镜子宫内膜切除术患者膨宫液吸收的影响 | Clinical Trial